TLX Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited (TLX) is confirmed to report earnings on August 19, 2026, after the market close. The consensus earnings estimate is $0.00 per share.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Th company is developing a portfolio of clinical and commercial stage products which aims to address significant unmet medical needs in oncology and rare diseases. Telix Pharmaceuticals Limited, formerly known as TLX PHARMACEUT, is based in MELBOURNE, Australia.
Sector
Healthcare
Industry
Biotechnology